These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12711562)

  • 21. [Pharmacological treatment of chronic heart failure in patients with renal failure].
    Stawicki S; Starczewska MH; Roik M; Opolski G
    Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of congestive heart failure].
    Aarønaes M; Atar D; Bonarjee V; Gundersen T; Løchen ML; Mo R; Myhre ES; Omland T; Rønnevik PK; Vegsundvåg J; Westheim A
    Tidsskr Nor Laegeforen; 2007 Jan; 127(2):174-7. PubMed ID: 17237864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of heart failure in the elderly patient with comorbidities.
    Briscoe TA; Earle SR; Lob MK; Somerville LL
    Director; 2004; 12(1):36-41. PubMed ID: 19178116
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diastolic heart failure -- a disease of the elderly].
    Witthaut R
    Dtsch Med Wochenschr; 2005 Mar; 130(12):704-9. PubMed ID: 15776355
    [No Abstract]   [Full Text] [Related]  

  • 31. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 32. The HF epidemic: the need for new treatment strategies.
    Carson PE
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
    McCall KL; Craddock D; Edwards K
    Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The defibrillator is not a comprehensive healing method].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Aug; 148(31-32):14. PubMed ID: 16938917
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
    Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
    Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options].
    Boldt LH; Rolf S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2349-54. PubMed ID: 18958832
    [No Abstract]   [Full Text] [Related]  

  • 37. Treating diastolic heart failure.
    Voors AA; de Jong RM
    Heart; 2008 Aug; 94(8):971-2. PubMed ID: 18625789
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 39. [Resynchronization, implantable defibrillator, CT coronary angiography. New options for your heart patients].
    Stiefelhagen P
    MMW Fortschr Med; 2009 Feb; 151(7):12-5. PubMed ID: 19432256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors].
    Kolber-Postepska B
    Wiad Lek; 1992 Dec; 45(23-24):903-6. PubMed ID: 1345233
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.